Boeing, Lockheed: Budget Cuts Hit Program Cash Flow, Backlog

Space IPO headlines are drawing attention away from a more terrestrial risk event for Boeing (BA) and Lockheed Martin (LMT). A set of program-level cuts across the Defense Department procurement pipeline tests the durability of each company's cash flow and backlog conversion. The risk is not that a SpaceX valuation re-rating steals thunder. The risk is that the orders underwriting the watchlist case for two of the largest government contractors face a structural budget shift.

Where the Lockheed and Boeing Program Cuts Land

The cuts target several development-stage programs that are not mature production contracts generating immediate revenue. For Lockheed Martin, the exposure runs through the Space Development Agency's Transport Layer program and parts of the Next-Generation Interceptor budget line. Lockheed books profit on progress milestones for these integration efforts. A cut delays milestone payments and pushes out free cash flow conversion.

For Boeing, the hit lands on the VC25B (Air Force One replacement) modification line and a portion of the MQ-25 drone tanker development. These are also delay-prone programs. Boeing's defense segment is already under cash consumption pressure. A reduction in scope here does not break the company. It removes one less lever for management to close the $3–4 billion free cash flow gap flagged for 2025 against consensus expectations.

Why the Backlog Figures Overstate Coverage

Both companies carry massive headline backlog numbers. Lockheed ended the last quarter with roughly $160 billion in backlog. Boeing's defense, space and security backlog stood at about $58 billion. The naive read is that this means revenue visibility for years. The better market read is that backlog includes undefinitized contract actions, options, and indefinite-delivery-indefinite-quantity (IDIQ) ceilings. Cuts at the program level hit the highest-conviction, most-likely-to-convert portions of that backlog first. What remains is lower probability and lower margin. The conversion risk rises precisely where investors assumed stability.

The Valuation Risk Beyond Earnings Multiple

At current levels, LMT trades at about 17.5x forward earnings, roughly in line with its five-year average. BA trades at a negative forward P/E on consensus that assumes a recovery in commercial deliveries and defense margins. The risk is that an erosion in defense backlog does not just reduce future earnings. It widens the discount rate investors apply to those earnings because it signals that government customers are willing to break the long-cycle procurement pattern that LMT and BA have relied on for predictable revenue.

Lockheed's Alpha Score 41/100 (Mixed label) reflects the tension between a low valuation at face value and the uncertainty over portfolio concentration. Boeing's Alpha Score 31/100 (Weak label) captures the same dynamic with worse execution risk.

What this means: A backlog hit in one program is not fatal. A pattern of cuts across the SDA, missile defense, and modification lines signals a structural budget shift. That changes the terminal value assumption for both names, not just the next quarter.

The Next Decision Points: Budget Request and Backlog Detail

The follow-up tests come in two forms. First, the FY 2026 budget request due from the administration in early 2025 will show whether these cuts are a one-year fix or a multiyear pivot. Second, both companies must report program-level backlog detail on their next earnings calls. If backlog declines sequentially in the segments where cuts were applied, the setup deteriorates. If they replace the lost work with new wins – particularly at LMT on classified programs or for BA on the T-7A trainer – the risk event closes.

Until then, the exposure is real. The space IPO hype does not change the budget math for two of the largest government contractors. The triggers are the defense appropriations committee markups in February and the program-level backlog disclosures on late January earnings calls. Those are the catalysts, not the IPO calendar. For a broader view, see our stock market analysis framework for defense equities.